Skip to content

Abnormal Amniotic Fluid Protein Concentration C5826749

Published: July 22, 2026Updated: August 20, 2026

A finding where the protein levels in the fluid surrounding an unborn baby are higher or lower than normal. It may require additional monitoring during pregnancy to check baby's health.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
N94.9
ICD-11
GA00.0
Body system
reproductive
Severity
mild
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Reduced fetal movements

Decreased perception of fetal kicks and movements, which may indicate fetal distress or compromised amniotic fluid environment.

Seek immediate medical attention if you notice significantly reduced fetal movements, especially if accompanied by other symptoms.

!

Vaginal fluid leakage

Unusual discharge or leakage of amniotic fluid from the vagina, which may indicate membrane rupture.

Seek immediate emergency care if you suspect amniotic fluid leakage, as this can lead to preterm labor and complications.

!

Preterm contractions

Regular or irregular uterine contractions occurring before 37 weeks of pregnancy.

Contact your healthcare provider immediately if you experience regular contractions before 37 weeks.

Abdominal cramping

(gastrointestinal)

Mild to moderate abdominal or uterine discomfort that may be persistent or intermittent.

Frequency: 40-50% of patients

Fundal height discrepancy

(reproductive)

Uterine size measured at prenatal visits is larger or smaller than expected for gestational age.

Frequency: 50-60% of patients

Fetal growth restriction

(constitutional)

Fetal size measured via ultrasound is smaller than expected for gestational age, often related to inadequate amniotic fluid.

Frequency: 15-20% of patients

Maternal hypertension

(cardiovascular)

Elevated blood pressure in the mother, which can be associated with abnormal amniotic fluid protein levels.

Frequency: 10-15% of patients

Abnormal ultrasound findings

(reproductive)

Ultrasound reveals abnormal amniotic fluid volume (polyhydramnios or oligohydramnios) or other structural concerns.

Frequency: 80-90% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Enhanced prenatal monitoring

Increased frequency of ultrasounds and fluid volume assessments to track amniotic protein levels and fetal development throughout pregnancy.

monitoring
2

Healthy lifestyle changes and stress management

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
3

Nutritional optimization

Balanced protein intake with appropriate vitamins and minerals supporting healthy amniotic fluid composition and fetal development.

dietary

Additional treatment options

Amnioinfusion (if indicated)

Transcervical or transabdominal infusion of fluid into the amniotic cavity to restore adequate volume when protein concentration indicates oligohydramnios.

procedure

Activity modification

Reduced physical strain with adequate rest and hydration to support optimal amniotic fluid dynamics during pregnancy.

lifestyle

Acupuncture support

Traditional acupuncture may complement conventional care by promoting circulation and supporting overall pregnancy wellness.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Amniotic Fluid Protein Concentration C5826749?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

American College of Obstetricians and Gynecologists. Practice Bulletin No. 204: Fetal Growth Restriction. Obstet Gynecol. 2019;133(2):e97-e109.

guideline2019View source →
2

Moore TR, Cayle JE. The amniotic fluid index in normal human pregnancy. Am J Obstet Gynecol. 1990;162(5):1168-1173.

review1990View source →
3

Ross MG, Beall MH. Amniotic Fluid Dynamics. In: Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice. 8th ed. Elsevier; 2019:125-138.

review2019
4

Society for Maternal-Fetal Medicine. Amniotic fluid: abnormal volume. Am J Obstet Gynecol. 2009;200(2):161.e1-161.e8.

guideline2009View source →
5

Magann EF, Sandlin AT, Ounpraseuth ST, et al. Amniotic fluid and the clinical relevance of the sonographically estimated amniotic fluid volume: oligohydramnios. J Ultrasound Med. 2011;30(11):1573-1585.

review2011View source →
6

Nabhan AF, Abdelmoula YA. Amniotic fluid index versus single deepest vertical pocket as a screening test for preventing adverse pregnancy outcome. Cochrane Database Syst Rev. 2008;(3):CD006593.

meta_analysis2008View source →
7

Cunningham FG, Leveno KJ, Bloom SL, et al. Williams Obstetrics. 25th ed. McGraw-Hill; 2018.

textbook2018
8

Chauhan SP, Sanderson M, Hendrix NW, Magann EF, Devoe LD. Perinatal outcome by amniotic fluid index in the periviable fetus. Am J Obstet Gynecol. 1999;181(5 Pt 1):1100-1103.

clinical_trial1999View source →
9

Magann EF, Chauhan SP, Doherty DA, Lutgendorf MA, Magann MI, Morrison JC. A review of idiopathic hydramnios and pregnancy outcomes. Obstet Gynecol Surv. 2007;62(12):795-802.

review2007View source →
10

National Institute for Health and Care Excellence. Inducing Labour. NICE Guideline No. 207. London: NICE; 2021.

consensus2021View source →

Medication Comparisons

Compare medications used to treat Abnormal Amniotic Fluid Protein Concentration C5826749. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy